BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1643465)

  • 1. Vanishing bile duct syndrome.
    Burra P; Elias E
    Br J Surg; 1992 Jul; 79(7):604-5. PubMed ID: 1643465
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis.
    Wiegand J; Neid M; Kaiser T; Wittekind C; Mössner J; Tillmann HL; Schiefke I
    Z Gastroenterol; 2006 Dec; 44(12):1227-9. PubMed ID: 17163373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis].
    Mandera M; Nowakowska-Duława E; Hartleb M
    Wiad Lek; 1992 May; 45(9-10):366-70. PubMed ID: 1441546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destructive intrahepatic bile duct diseases.
    Desmet VJ
    Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis.
    Nakanuma Y; Ohta G; Yamazaki Y; Doishita K
    Acta Pathol Jpn; 1979 Mar; 29(2):211-9. PubMed ID: 552794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa.
    Goritsas CP; Repanti M; Papadaki E; Lazarou N; Andonopoulos AP
    J Hepatol; 1997 Mar; 26(3):727-30. PubMed ID: 9075683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of chronic cholestasis and adult ductopenic syndrome.
    Desmet VJ
    Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.
    Forbes GM; Jeffrey GP; Shilkin KB; Reed WD
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1385-8. PubMed ID: 1551543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of intrahepatic cholestasis syndrome].
    Kraus MR; Scheurlen M
    MMW Fortschr Med; 2004 Jun; 146(23):34-7. PubMed ID: 15373130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
    Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
    Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
    Kochar R; Nevah MI; Lukens FJ; Fallon MB; Machicao VI
    World J Gastroenterol; 2010 Jul; 16(26):3335-8. PubMed ID: 20614492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
    Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
    J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.